Financial Data and Key Metrics Changes - Sales increased 31% year-over-year to a record 9.4million,representing12800,000 year-over-year to 7.5million[4][17]−Netlosswas25.3 million in Q2 2024, compared to a net loss of 10.7millionintheprioryearperiod[16][17]−AdjustedgrossmarginforQ2wasapproximately29175 million in financing, which would bring total committed future capital to approximately $400 million [12] - Significant strides have been made in optimizing seed costs, achieving a reduction of approximately 20% [9] Q&A Session Summary Question: Contribution of Texas and Pasco in the back half of the year - Management highlighted the positive impact of new SKUs and customer demand on revenue and margin in the second half [21][22] Question: Details on the sale-leaseback of the Georgia facility - Management indicated that the strategy involves transitioning facilities to sale-leaseback once they reach profitability, with expectations for Texas and Washington to follow suit [27][28] Question: Sequential shift in EBITDA from Q1 to Q2 - Management explained that the increase in EBITDA loss was due to lower revenue from Montana and some elevated costs associated with new facility operations [30][31] Question: Doubling capacity in Texas and Washington - Management confirmed that land has been secured for expansion, and the facilities are designed to accommodate increased production without significant disruption [32][33] Question: Updates on the Midwest facility - Management noted that the Midwest build is being adjusted to meet customer demand and may involve a larger scale than initially planned [36][37]
